About MEDS
MEDS is a company based in Stockholm (Sweden) founded in 2017 by Bjorn Thorngren.. MEDS has raised $26.34 million across 2 funding rounds from investors including M2 Asset Management AB and Inbox Capital. MEDS offers products and services including MEDS Online Platform, Prescription Management Service, and Beauty Product Catalog. MEDS operates in a competitive market with competitors including Apoteket, Apotek Hjrtat, Apotea, Apotekamo and Apohem, among others.
- Headquarter Stockholm, Sweden
- Founders Bjorn Thorngren
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Meds Apotek Ab
-
Annual Revenue
$75.61 M (USD)30.64as on Dec 31, 2024
-
Net Profit
$-948.32 K (USD)78.95as on Dec 31, 2024
-
EBITDA
$420.67 K (USD)0as on Dec 31, 2024
-
Total Equity Funding
$26.34 M (USD)
in 2 rounds
-
Latest Funding Round
$20.61 M (USD), Series B
Jan 21, 2021
-
Investors
M2 Asset Management AB
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MEDS
MEDS is a publicly listed company on the OMXSTO with ticker symbol MEDS in Sweden. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of MEDS
MEDS offers a comprehensive portfolio of products and services, including MEDS Online Platform, Prescription Management Service, and Beauty Product Catalog. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for ordering medications and health products online
Tool for handling and refilling prescriptions digitally
Collection of skincare and personal care items for purchase
Unlock access to complete
Funding Insights of MEDS
MEDS has successfully raised a total of $26.34M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $20.61 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $20.6M
-
First Round
First Round
(11 Jan 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Series B - MEDS | Valuation | M2 Asset Management AB |
|
| Jan, 2019 | Amount | Series A - MEDS | Valuation | Inbox Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MEDS
MEDS has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include M2 Asset Management AB and Inbox Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech-focused VC firm investing primarily in Sweden
|
Founded Year | Domain | Location | |
|
Invests in and manages real estate properties, develops assets, and handles financial reporting in Sweden.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MEDS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MEDS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Meds Comparisons
Competitors of MEDS
MEDS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apoteket, Apotek Hjrtat, Apotea, Apotekamo and Apohem, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Operates an online store for purchasing medicines and healthcare products.
|
|
| domain | founded_year | HQ Location |
Pharmacy chain operated across Sweden with online retail services.
|
|
| domain | founded_year | HQ Location |
Online pharmacy store
|
|
| domain | founded_year | HQ Location |
Medicines and health products are offered online for home delivery.
|
|
| domain | founded_year | HQ Location |
Online drug store
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Meds
Frequently Asked Questions about MEDS
When was MEDS founded?
MEDS was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is MEDS located?
MEDS is headquartered in Stockholm, Sweden.
Who is the current CEO of MEDS?
Bjorn Thorngren is the current CEO of MEDS. They have also founded this company.
Is MEDS a funded company?
MEDS is a funded company, having raised a total of $26.34M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5.73M, raised on Jan 11, 2019.
What is the annual revenue of MEDS?
Annual revenue of MEDS is $75.61M as on Dec 31, 2024.
What does MEDS do?
MEDS was founded in 2017 in Stockholm, Sweden, and operates as an online pharmacy in the healthcare sector. Prescription and over-the-counter medicines are offered, along with food supplements and products for categories such as fever and aches, skin care, intimate care, stomach and intestines. Cosmetics and beauty items are also included in the catalog, with services provided through the domain meds.se.
Who are the top competitors of MEDS?
MEDS's top competitors include Apotek Hjrtat, Apotea and Apotekamo.
What products or services does MEDS offer?
MEDS offers MEDS Online Platform, Prescription Management Service, and Beauty Product Catalog.
Is MEDS publicly traded?
Yes, MEDS is publicly traded on OMXSTO under the ticker symbol MEDS.
Who are MEDS's investors?
MEDS has 2 investors. Key investors include M2 Asset Management AB, and Inbox Capital.
What is MEDS's ticker symbol?
The ticker symbol of MEDS is MEDS on OMXSTO.